Genetic Signatures (ASX:GSS) EV-to-EBITDA : -7.00 (As of May. 23, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Genetic Signatures's enterprise value is A$123.65 Mil. Genetic Signatures's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-17.68 Mil. Therefore, Genetic Signatures's EV-to-EBITDA for today is -7.00.

The historical rank and industry rank for Genetic Signatures's EV-to-EBITDA or its related term are showing as below:

ASX:GSS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -261.5 Med: -9.31 Max: 71.51
Current: -7

During the past 9 years, the highest EV-to-EBITDA of Genetic Signatures was 71.51. The lowest was -261.50. And the median was -9.31.

ASX:GSS's EV-to-EBITDA is ranked worse than
100% of 114 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.635 vs ASX:GSS: -7.00

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Genetic Signatures's stock price is A$0.76. Genetic Signatures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.125. Therefore, Genetic Signatures's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Genetic Signatures EV-to-EBITDA Historical Data

The historical data trend for Genetic Signatures's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures EV-to-EBITDA Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBITDA

Get a 7-Day Free Trial

-44.40

-236.05

39.63

27.56

-4.71

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial													-	27.56	-	-4.71	-

Competitive Comparison of Genetic Signatures's EV-to-EBITDA

For the Diagnostics & Research subindustry, Genetic Signatures's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's EV-to-EBITDA falls into.

Genetic Signatures EV-to-EBITDA Calculation

Genetic Signatures's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	123.645	/	-17.675
	=	-7.00

Genetic Signatures's current Enterprise Value is A$123.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genetic Signatures's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-17.68 Mil.

Genetic Signatures (ASX:GSS) EV-to-EBITDA Explanation

Genetic Signatures's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.76	/	-0.125
	=	At Loss

Genetic Signatures's share price for today is A$0.76.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genetic Signatures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.125.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Genetic Signatures EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.